Publications: Kibble, Emily

Journal Article

Iwasaki, J., Lorimer, D.D., Vivoli-Vega, M., Kibble, E.A., Peacock, C.S., Abendroth, J., Mayclin, S.J., Dranow, D.M., Pierce, P.G., Fox, D., Lewis, M., Bzdyl, N.M., Kristensen, S.S., Inglis, T.J.J., Kahler, C.M., Bond, C.S., Hasenkopf, A., Seufert, F., Schmitz, J., Marshall, L.E., Scott, A.E., Norville, I.H., Myler, P.J., Holzgrabe, U., Harmer, N.J. and Sarkar-Tyson, M. (2022) Broad-spectrum in vitro activity of macrophage infectivity potentiator inhibitors against Gram-negative bacteria and Leishmania major. Journal of Antimicrobial Chemotherapy, 77 (6). pp. 1625-1634.

Lim, K.Y.L., Mullally, C.A., Haese, E.C., Kibble, E.A., McCluskey, N.R., Mikucki, E.C., Thai, V.C., Stubbs, K.A., Sarkar-Tyson, M. and Kahler, C.M. (2021) Anti-virulence therapeutic approaches for Neisseria gonorrhoeae. Antibiotics, 10 (2). Article 103.

Scheuplein, N.J., Bzdyl, N.M., Kibble, E.A., Lohr, T., Holzgrabe, U. and Sarkar-Tyson, M. (2020) Targeting protein folding: A novel approach for the treatment of pathogenic bacteria. Journal of Medicinal Chemistry, 63 (22). pp. 13355-13388.

Thesis

Kibble, Emily A. (2021) The role of FK506 Binding Proteins in the virulence of Neisseria meningitidis. PhD thesis, Murdoch University.